As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new estimates from Cambridge researchers. Previous estimates ...
A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...
Researchers sought to determine the local recurrence and overall survival with breast conserving therapy in cases of multifocal or multicentric breast cancer.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
Early detection is the key to surviving lung cancer, but Oklahomans rank 44th out of 47 states in early-stage diagnosis ...
Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...
Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.
BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...
BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...
Sydney, Australia Friday, March 28, 2025, 18:00 Hrs [IST] ...
Johnson & Johnson’s (J&J’s) Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) combination therapy is projected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback